维普中文期刊产品整合服务
35篇 您的检索式:作者名="Taskinen E"
    题名 作者 年代 出处 被引量
1Increased volume of gastric contents in diabetic patients undergoing renal transplantation: lack of effect with cisapride显示文摘 Taskinen MR Orko R 1992Acta Anaesthesiol Scand1992,36,7:1
2Histological chronic allograft damage index accurately predicts chronic renal allograft rejection显示文摘Isoniemi H Taskinen E Hayry P 1994Transplantation1994,58,11:1
3Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterol- emia: Results of a 24 week, double-blind, randomized Phase 3 trial显示文摘ROTH E M TASKINEN M R GINSBERG H N 2014International Journal of Cardiology2014,176,:1
4Protocol core biopsy :a surrogate marker for chronic rejection显示文摘 Taskinen E Paavonen T 2000Transplan Proc2000,32,:1
5Relation of plasma high density lipoprotein cholesterol to lipoprotein lipase activity in adipose tissue and skeletal muscle of man 显示文摘NIKKILA E A TASKINEN M R KEKKI M 1978Atherosclerosis1978,29,:1
6Expression of Adhesion Molecules in liver allografts during acute amd chronic rejection显示文摘Lautenschlager I Hockerstedt K Taskinen E 1997Transplant Proc1997,29,:1
7Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial显示文摘AC Keech P Mitchell PA Summanen J O'Day TME Davis MS Moffitt M-R Taskinen RJ Simes D Tse E Williamson A Merrifield LT Laatikainen MC d'Emden DC Crimet RL O'Connell PG Colman 2007The Lancet2007,,9600:1
8Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta显示文摘 Savolainen H Aavik E Myllarniemi M Strauss L Taskinen E 1999Proc Natl Acad Sci USA1999,96,12:1
9Bedtime insulin forsuppression of overnight free-fatty acid, blood glucose, and glucoseproduction inNIDDM显示文摘Taskinen MR Sane T Helve E 1989Diabetes1989,38,5:1
10Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years显示文摘Mota A Arias M Taskinen E 2004Am J Transplant2004,4,95:1
11Clinical significance of cerebrospinal fluid cytology显示文摘Taskinen E Livanairen M 2009Neurosurg2009,105,20:1
12Recurrnce and malgnat transformation of endotraeheal chondroma显示文摘Salminen US Halttunen P Taskinen E 0,,05:1
13Chronic allograft nephropathy is prevented by inhibition of plateletderived growth factor receptor:tyrosine kinase inhibitors as a potential therapy 显示文摘Savikko J Taskinen E Von Willebrand E 2003Transplantation2003,75,8:1
14The specificity of glucuronidartion of enlacapone and tolcapone by recombinant hunman UDP-glucuronosyltransferases 显示文摘Lautala E Ethell BT Taskinen J 2000Drug Metab Dispos2000,28,11:1
15Monotherapy with the PCSK9inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia:results of a 24week,double-blind,randomized phase 3trial显示文摘ROTH E M TASKINEN M R GINSBERG H N 2014Int J Cardiol2014,176,:1
16Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years显示文摘Mota A Arias M Taskinen E 2004Am J Transplantatin2004,4,6:1
17Prognostic im- pact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy显示文摘Taskinen M Jantunen E Kosma VM 2010EurJ Cancer2010,46,13:1
18Periopemtive stroke in cor- otry artery bypass patients 显示文摘Loponen P Taskinen P Laakkonen E 2003Scand J Surg2003,92,:1
19Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial显示文摘AC Keech P Mitchell PA Summanen J O’Day TME Davis MS Moffitt M-R Taskinen RJ Simes D Tse E Williamson A Merrifield LT Laatikainen MC d’Emden DC Crimet RL O’Connell PG Colman 2007The Lancet . 2007 (9600)2007,,9600:1
20Insulin therapy induce antiacherogenic changes of serum lipeprocins in Non-Insulin-Dependent-Diabetics 显示文摘Taskinen M R Kuusi T Helve E 1988Arteriosclerosis1988,8,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费